- Disrupting the Solid Tumor Environment Using CAR T Therapies
- CAR T-Cell Therapy: Overcoming Toxicities
- Gene-Modulation Technologies in the Development of Cell-based Therapies
- From Boutique to Global: Chimeric Antigen Receptor T-Cells as a Model for Clinical Development and Commercialization
- Gaining Critical Characterization Insights for the Development of CAR-T Therapies for Solid Tumors
- CAR T-cell Therapy and Bispecific Antibodies: Frontiers in Cancer Immunotherapy
- Brochure: Smarter Technologies for Advancing the Next Generation of CAR-T Therapies | July 2020
- Intellicyt® iQue3 Faster, Smarter Flow Cytometry
- Incucyte® S3 Brochure
- Microsart® ATMP Mycoplasma — Rapid Real-time PCR Mycoplasma Detection Kit for testing ATMPs
- Microsart® RESEARCH Mycoplasma — Mycoplasma Detection Kit for qPCR
- Application in Action: Multiplexing Secreted Protein Screening, Proliferation and Immunopheotyping of PBMCs on the iQue Platform
- A Kinase Inhibitor Phenotypic Screen Using A Multiplex T Cell Activation Assay
- How to Avoid Contamination in Pipetting
- Rapid, Real Time Quantification of Lentivirus Particles Using Antibody-Based Detection on the Virus Counter® 3100 Platform
- Gaining Critical Characterization Insights for Development of CAR-T Therapies for Solid Tumors
- Novel Trends in Immuno-Oncology Research: Advanced Cell Analysis for Immunotherapeutic Applications
- Immuno-Oncology Profiling for Drug Discovery and Translational Research
- Smarter Solutions for Next-Gen CAR-T Development
- Validation of Novel Continuous Live-Cell Assays for Immune Cell Activation and Killing of Blood Cell Cancers
- 96-Well Live-Cell Assays for Immune Cell Killing of 3D Tumour Spheroids
- Impact of Pipetting Errors on Reproducibility of Cell-Based Assays
- Optimized T Cell Profiling Assay to Improve Ex Vivo Expansion